Get the Stockscreener App
0.835
2.92%
0.0237
After Hours:
.83
-0.005
-0.60%
iBio Inc stock is traded at $0.835, with a volume of 365.93K.
It is up +2.92% in the last 24 hours and up +34.05% over the past month.
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
See More
Previous Close:
$0.8113
Open:
$0.8052
24h Volume:
365.93K
Relative Volume:
0.16
Market Cap:
$16.41M
Revenue:
$2.05M
Net Income/Loss:
$-23.15M
P/E Ratio:
-0.1259
EPS:
-6.6319
Net Cash Flow:
$-16.93M
1W Performance:
+2.12%
1M Performance:
+34.05%
6M Performance:
-86.81%
1Y Performance:
-54.37%
1-Day Range:
$0.7999
$0.8395
1-Week Range:
$0.771
$0.86
52-Week Range:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
Name
iBio Inc
Sector
Industry
Phone
302-355-0650
Address
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
0.835 | 15.95M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-24 | Initiated | Chardan Capital Markets | Buy |
| Nov-29-21 | Initiated | JMP Securities | Mkt Outperform |
| Jan-22-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-26-20 | Initiated | Alliance Global Partners | Buy |
iBio Inc Stock (IBIO) Latest News
Is a relief rally coming for iBio Inc. holdersWeekly Profit Report & Technical Buy Zone Confirmations - Newser
What hedge funds are buying iBio Inc.July 2025 Levels & Fast Gain Swing Trade Alerts - خودرو بانک
Can iBio Inc. be recession proofEarnings Overview Report & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Ibio Inc’s Future at Risk: Reliance on Third-Party Licenses for Key Product Candidates - TipRanks
iBio, Inc. Reports Transformative Fiscal Year 2025 - TipRanks
Brookline Capital Markets reiterates Buy rating on iBio stock with $1.60 target - Investing.com India
What MACD and RSI say about iBio Inc.Market Sentiment Review & Entry Point Confirmation Signals - Newser
Brookline Capital Markets reiterates Buy rating on iBio stock with $1.60 target By Investing.com - Investing.com South Africa
Why is iBio Inc. stock going upJuly 2025 Update & Risk Controlled Swing Trade Alerts - خودرو بانک
Is iBio Inc. trending in predictive chart modelsWeekly Trade Report & AI Enhanced Trade Execution Alerts - Newser
IBio, Inc. Reports Earnings Results for the Full Year Ended June 30, 2025 - MarketScreener
iBio, Inc. SEC 10-K Report - TradingView
iBio Sets Sights on Clinic for Treatments of Obesity, Heart Disease - San Diego Business Journal
iBio Reports Fiscal Year 2025 Financial Results and Provides Cor - GuruFocus
iBio (IBIO) Reports Revenue Growth and Strategic Advancements - GuruFocus
iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update - The Manila Times
Multi asset correlation models including iBio Inc.2025 Key Highlights & Entry Point Confirmation Alerts - Newser
Does iBio Inc. fit your quant trading modelGap Down & Low Drawdown Momentum Ideas - Newser
Multi factor analysis applied to iBio Inc.Market Risk Report & Free High Accuracy Swing Entry Alerts - Newser
Volatility clustering patterns for iBio Inc.Weekly Trade Analysis & Risk Controlled Daily Trade Plans - Newser
Is iBio Inc. undervalued by DCF analysisInsider Selling & Entry Point Strategy Guides - خودرو بانک
What’s the analyst consensus on iBio Inc.Weekly Stock Recap & Growth Focused Investment Plans - خودرو بانک
What earnings revisions data tells us about iBio Inc.Weekly Trade Report & AI Enhanced Trade Execution Alerts - Newser
Is now a turning point for iBio Inc.July 2025 News Drivers & Expert Approved Momentum Trade Ideas - Newser
Backtesting results for iBio Inc. trading strategiesJuly 2025 Technicals & Long-Term Safe Investment Ideas - Newser
Can technical indicators confirm iBio Inc.’s reversal2025 Technical Patterns & Long-Term Safe Investment Plans - Newser
Sector ETF performance correlation with iBio Inc.Quarterly Investment Review & Precise Buy Zone Identification - Newser
Volume spikes in iBio Inc. stock – what they mean2025 Performance Recap & Consistent Income Trade Ideas - Newser
Using portfolio simulators with iBio Inc. includedEarnings Risk Report & Consistent Growth Equity Picks - Newser
What’s next for iBio Inc. stock priceWeekly Market Report & Precise Entry and Exit Recommendations - Newser
Is iBio Inc. forming a reversal patternJuly 2025 Sentiment & Expert Verified Movement Alerts - Newser
iBio Inc. stock daily chart insights2025 Momentum Check & Reliable Entry Point Trade Alerts - Newser
iBio Inc. stock chart pattern explained2025 Trading Recap & AI Forecast for Swing Trade Picks - Newser
Can iBio Inc. expand its profit marginsEarnings Overview Report & Daily Stock Trend Watchlist - خودرو بانک
How to escape a deep drawdown in iBio Inc.Analyst Upgrade & Advanced Swing Trade Entry Plans - Newser
Can you recover from losses in iBio Inc.Breakout Watch & AI Based Buy/Sell Signal Reports - Newser
Will iBio Inc. benefit from AI trends2025 Short Interest & Accurate Entry and Exit Point Alerts - خودرو بانک
Is iBio Inc. a play on infrastructure spendingWeekly Gains Report & AI Enhanced Trading Alerts - خودرو بانک
Best data tools to analyze iBio Inc. stockWeekly Loss Report & Verified Momentum Stock Ideas - Newser
Is iBio Inc. attractive at current valuation2025 Growth vs Value & Weekly Top Gainers Alerts - خودرو بانک
Is iBio Inc. stock a hidden gemGDP Growth & Growth Focused Stock Pick Reports - خودرو بانک
Technical signs of recovery in iBio Inc.2025 Institutional Moves & AI Powered Buy and Sell Recommendations - Newser
iBio Inc Stock (IBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):